Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma

Update Il y a 4 ans
Reference: EUCTR2010-020447-13

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess the progression-free survival (PFS) in patients who receive everolimus as second-line treatment for metastatic renal cell carcinoma


Inclusion criteria

  • Metastatic Renal Cell Carcinoma

Links